Idera Pharmaceuticals, Inc (IDRA) Covered Calls

Idera Pharmaceuticals, Inc covered calls Idera Pharmaceuticals, Inc. is a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-Like Receptors, to treat infectious diseases, autoimmune and inflammatory diseases, cancer etc.

You can sell covered calls on Idera Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IDRA (prices last updated Wed 4:16 PM ET):

Idera Pharmaceuticals, Inc (IDRA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.68 -0.08 6.23 7.27 100K - 0.0B
Covered Calls For Idera Pharmaceuticals, Inc (IDRA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 7 0.00 7.27 -3.7% -135.1%
Jan 18 7 0.15 7.12 -1.7% -16.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which is engaged in discovery, development and commercialization of novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal and James B. Wyngaarden in May 25, 1989 and is headquartered in Cambridge, MA.